Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption

Abstract

Cellular models of organs have been used to investigate mechanisms of disease. Here the authors generate a human alpha synuclein-induced brain-chip model that recapitulates blood-brain barrier dysfunction, as a potential testing platform for novel therapeutics in Parkinson’s disease.